Cannabis, Schizophrenia Risk and Genetics: A Case Report of a Patient With Homozygous Valine Catechol-O-Methyltransferase Polymorphism
| Autor: | Vatsala Sharma, Ayodeji Jolayemi, Heela Azizi, Tasmia Khan, Katelyn Grechuk |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
cannabis
gene polymorphisms Psychosis medicine.medical_specialty CATECHOL-O-METHYLTRANSFERASE POLYMORPHISM behavioral disciplines and activities Cannabis intoxication Polymorphism (computer science) val158met mental disorders Genetics medicine psychosis comt Psychiatry biology business.industry General Engineering Cannabis use medicine.disease biology.organism_classification schizophrenia Neurology Schizophrenia Comt polymorphism Cannabis business |
| Zdroj: | Cureus |
| ISSN: | 2168-8184 |
| DOI: | 10.7759/cureus.15740 |
| Popis: | The question of whether cannabis can trigger schizophrenia continues to be a subject of interest. There has been an increasing focus on identifying potential genetic factors that may predispose cannabis users to develop schizophrenia. One such gene identified in many studies codes for a catechol-O-methyltransferase (COMT) enzyme polymorphism. These studies, however, are limited by the inclusion of patients displaying psychotic symptoms during cannabis intoxication and those who continue to display psychotic symptoms after its cessation. The latter is of interest in truly understanding the risk of cannabis triggering schizophrenia and more studies are needed to clarify the potential relationship. We present the case of a 24-year-old female who presented with psychotic symptoms and was diagnosed with schizophrenia after extensive cannabis use. In addition, she had a homozygous valine COMT polymorphism, a genetic variant thought to be associated with a predisposition for schizophrenia in cannabis users. We discuss the significance of our findings in understanding the relationship between cannabis use and the development of schizophrenia in genetically predisposed individuals. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|